India's Supreme Court clears Daiichi Sankyo's disputed Zenotech offer
This article was originally published in Scrip
Executive Summary
Shares of the Indian biotech firm, Zenotech Laboratories, fell sharply on the Bombay Stock Exchange (BSE) after the Supreme Court of India upheld Daiichi Sankyo's offer price of Rs113.62 ($2.42) per share for the acquisition of an additional 20% stake in the company.